RenalGuard® - A
Therapeutic Approach to Reducing Contrast-Induced
Nephropathy*
RenalGuard
Therapy® is
designed to reduce the toxic effects that contrast media can have on the kidneys.
This therapy is based on the
theory that creating and maintaining a high urine output is beneficial to patients
undergoing imaging
procedures where contrast
agents are used.
The real-time measurement and matched fluid replacement design of the RenalGuard System ™ is intended to ensure that a high urine flow is maintained before, during and after these procedures. This should allow the body to rapidly eliminate contrast, reducing its toxic effects.
The
RenalGuard System with its matched fluid replacement capability
is
intended to minimize the risk of over-or under-hydration.
The use of the system may
help reduce the
incidence of Contrast-Induced
Nephropathy
(CIN), a form of
Acute
Renal Failure caused by contrast media during coronary angiograms, coronary
interventions and other
image-guided cardiology
and
radiology procedures.